Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib plus capecitabine for untreated brain metastases from HER2-positive breast cancer
2008-001084-10Phase 2Completed
- Sponsor
- Unicancer
- Start
- Oct 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib, capecitabine in breast cancer, brain metastases, sponsored by Unicancer. Started Oct 2008; status: completed.
02
Drugs
lapatinibcapecitabine
03
Conditions
breast cancerbrain metastases
Beyond the preview
Go deeper on 2008-001084-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001084-10.